Literature DB >> 7042537

Neoplastic B cells as targets for antibody-ricin A chain immunotoxins.

E S Vitetta, K A Krolick, J W Uhr.   

Abstract

Mesh:

Substances:

Year:  1982        PMID: 7042537     DOI: 10.1111/j.1600-065x.1982.tb00393.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


× No keyword cloud information.
  18 in total

1.  Readily available fluorescein isothiocyanate-conjugated antibodies can be easily converted into targeted phototoxic agents for antibacterial, antiviral, and anticancer therapy.

Authors:  S Devanathan; T A Dahl; W R Midden; D C Neckers
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

2.  Secretion of idiotypic IgM by the mouse B-cell leukaemia (BCL1) occurs spontaneously in vitro and in vivo.

Authors:  A L Tutt; F K Stevenson; S Slavin; G T Stevenson
Journal:  Immunology       Date:  1985-05       Impact factor: 7.397

3.  Antibody-targeted photolysis: selective photodestruction of human T-cell leukemia cells using monoclonal antibody-chlorin e6 conjugates.

Authors:  A R Oseroff; D Ohuoha; T Hasan; J C Bommer; M L Yarmush
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

4.  Cloning and expression of recombinant, functional ricin B chain.

Authors:  M S Chang; D W Russell; J W Uhr; E S Vitetta
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

5.  Use of anti-idiotypic antibodies to demonstrate rheumatoid factor producing bone marrow cells in essential mixed cryoglobulinaemia.

Authors:  A E Gharavi; G Campion; G R Hughes
Journal:  Ann Rheum Dis       Date:  1984-08       Impact factor: 19.103

Review 6.  Immunoglobulin idiotypes; experimental and clinical applications.

Authors:  A K Abbas
Journal:  Indian J Pediatr       Date:  1982 Sep-Oct       Impact factor: 1.967

7.  Monoclonal antibody and an antibody-toxin conjugate to a cell surface proteoglycan of melanoma cells suppress in vivo tumor growth.

Authors:  T F Bumol; Q C Wang; R A Reisfeld; N O Kaplan
Journal:  Proc Natl Acad Sci U S A       Date:  1983-01       Impact factor: 11.205

8.  Synergy of ricin A chain-containing immunotoxins and ricin B chain-containing immunotoxins in in vitro killing of neoplastic human B cells.

Authors:  E S Vitetta; W Cushley; J W Uhr
Journal:  Proc Natl Acad Sci U S A       Date:  1983-10       Impact factor: 11.205

9.  Comparison of blocked and non-blocked ricin-antibody immunotoxins against human gastric carcinoma and colorectal adenocarcinoma cell lines.

Authors:  L Cattel; L Delprino; P Brusa; F Dosio; P M Comoglio; M Prat
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

10.  Pharmacological studies of ricin in mice and humans.

Authors:  A Godal; O Fodstad; K Ingebrigtsen; A Pihl
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.